Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Risperidone-Induced Pisa Syndrome in MS: Resolution with Lurasidone and Recurrence with Chlorpromazine.
Unusual Presentation of Unilateral Isolated Probable Lyme Optic Neuritis.
The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.
Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
Finding benefit in stressful uncertain circumstances: relations to social support and stigma among women with unexplained illnesses.
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
The active form of vitamin D transcriptionally represses the Smad7 signaling and activates ERK to inhibit the differentiation of a inflammatory T helper cell subset and suppress experimental autoimmune encephalomyelitis.
Lower urinary tract symptoms associated with neurological conditions: Observations on a clinical sample of outpatients neurorehabilitation service.
Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.
Alpha lipoic acid enhances endogenous peroxisome proliferator-activated receptor-γ to ameliorate experimental autoimmune encephalomyelitis.
Increased incidence of multiple sclerosis in the Veneto region, Italy.
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
Migration of the Fatigue Symptoms and Impacts Questionnaire-Relapsing Multiple Sclerosis (Fsiq-Rms(tm)) from Paper to an Electronic Diary Format.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
B-type suppression: A role played by "regulatory B cells" or "regulatory plasma cells"?
Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.
Minimal supportive treatment in natalizumab-related PML in a MS patient.
Commentary on 'Disability outcome measures in multiple sclerosis clinical trials'
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.
Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy.
Impaired early B cell tolerance in patients with rheumatoid arthritis.
Stop the silent misdiagnosis: patients' preferences matter.
Is Neuromyelitis Optica with Advanced Age of Onset a Paraneoplastic Disorder?
Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?
Pages
« first
‹ previous
…
455
456
457
458
459
460
461
462
463
…
next ›
last »